Skip to content
Disclosery

EXANE DERIVATIVES: CB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,090 CB shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,090 shares
    Change vs previous 13F -1,334 shares

    0.46% of the 13F portfolio, value $803,848.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 5,424 shares
    Change vs previous 13F +116 shares

    0.33% of the 13F portfolio, value $1,160,122.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,308 shares
    Change vs previous 13F -2,076 shares

    0.25% of the 13F portfolio, value $1,026,052.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7,384 shares
    Change vs previous 13F -447 shares

    0.32% of the 13F portfolio, value $1,280,930.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,831 shares
    Change vs previous 13F +419 shares

    0.3% of the 13F portfolio, value $1,276,580.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,412 shares
    Change vs previous 13F +365 shares

    0.35% of the 13F portfolio, value $1,170,822.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,047 shares
    Change vs previous 13F not available

    0.33% of the 13F portfolio, value $1,084,624.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).